Company La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
Business Summary
Number of employees: 61
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Hearne
DFI | Director of Finance/CFO | 61 | 31/05/20 |
Tony Hodges
CTO | Chief Tech/Sci/R&D Officer | - | 11/09/21 |
Luke Seikkula
COO | Chief Operating Officer | 60 | 31/12/18 |
Paula Rusu
PRN | Corporate Officer/Principal | - | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marianne Zhen
BRD | Director/Board Member | 55 | 21/08/22 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 21/08/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,936,883 | 24,826,697 ( 99.56 %) | 0 | 99.54 % |
Stock B | 0 | 3,907 | 0 | 0 |
Company contact information
La Jolla Pharmaceutical Co.
201 Jones Road Suite 400
02451, Waltham
+617 715 3600
https://www.lajollapharmaceutical.comSector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |